Company Information
Member Since 4 Years
Nature of Business Exporter
GST No. 07ABEFM6994Q2Z7Ask for more detail from the seller
Contact Supplier
FDA Approves Capecitabine, First Oral Chemotherapy for the Treatment of Metastatic Colorectal Cancer. The US Food and Drug Administration (FDA) has approved capecitabine (Xeloda), the first oral chemotherapy for the treatment of metastatic colorectal cancer (the second leading cause of cancer mortality among Americans).
Â
The FDA has approved the first generic formulation of capecitabine (Xeloda), an oral chemotherapeutic that is currently approved to treat patients with metastatic colorectal cancer (mCRC) and metastatic breast cancer (MBC). XELODA (capecitabine) is a nucleoside metabolic inhibitor with antineoplastic activity indicated for:
Connect with us
For Buyer 
For Seller 
Help 
Okhla, Delhi 
Send Enquiry